DEA schedule
Is dalfampridine a controlled substance?
Federal schedule for dalfampridine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Dalfampridine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and dalfampridine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted dalfampridine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 11 prescription listings from 10 labelers, none with a DEA schedule |
| DEA controlled substances list | dalfampridine is not on the list |
Dalfampridine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0259-5010 | AMPYRA | tablet, film coated, extended release | 10 mg/1 | Merz Pharmaceuticals, LLC | None |
| 10144-427 | AMPYRA | tablet, film coated, extended release | 10 mg/1 | Merz Pharmaceuticals, LLC | None |
| 42571-275 | DALFAMPRIDINE | tablet, extended release | 10 mg/1 | Micro Labs Limited | None |
| 62756-429 | Dalfampridine | tablet, extended release | 10 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
| 72162-2459 | DALFAMPRIDINE | tablet, extended release | 10 mg/1 | Bryant Ranch Prepack | None |
| 0591-2533 | Dalfampridine | tablet, film coated, extended release | 10 mg/1 | Actavis Pharma, Inc. | None |
| 16729-292 | Dalfampridine | tablet, film coated, extended release | 10 mg/1 | Accord Healthcare Inc. | None |
| 51407-876 | Dalfampridine | tablet, film coated, extended release | 10 mg/1 | Golden State Medical Supply, Inc. | None |
| 65862-863 | DALFAMPRIDINE | tablet, film coated, extended release | 10 mg/1 | Aurobindo Pharma Limited | None |
| 67877-444 | Dalfampridine | tablet, film coated, extended release | 10 mg/1 | Ascend Laboratories, LLC | None |
| 82249-702 | Dalfampridine | tablet, film coated, extended release | 10 mg/1 | CivicaScript LLC | None |
Questions
Is dalfampridine a controlled substance?
No. Dalfampridine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and dalfampridine is not on the DEA controlled substances list.
Is dalfampridine a narcotic?
No. Dalfampridine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Potassium Channel Blocker.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.